# Transcranial Ultrasound in Clinical SONothrombolysis

> **NCT00504842** · PHASE1,PHASE2 · TERMINATED · sponsor: **ImaRx Therapeutics** · enrollment: 72 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** MRX-801
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00504842
- **Lead sponsor:** ImaRx Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 72 (ESTIMATED)
- **Why stopped:** Sponsor decision
- **Last updated:** 2008-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504842, "Transcranial Ultrasound in Clinical SONothrombolysis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00504842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*